期刊文献+

活化T细胞核因子在吡格列酮预防非肥胖糖尿病小鼠糖尿病中作用机制的探讨 预览

The mechanism study of NFAT in pioglitazone prevent diabetes of NOD mice
在线阅读 下载PDF
收藏 分享 导出
摘要 目的探讨吡格列酮预防非肥胖糖尿病(NOD)小鼠糖尿病的机制及活化T细胞核N子(NFAT)的作用。方法(1)将4周龄NOD雌鼠随机分为吡格列酮组(摄食含0.02%吡格列酮的混合饲料)及对照组(普通营养饲料),各21只。观察30周龄的累积糖尿病发病率。(2)各组取12周龄未发病NOD鼠(n=15)胰腺苏木素-伊红(HE)染色观察胰岛炎的严重程度;RT-PCR半定量检测脾脏白细胞介素4(IL-4)、了干扰素(IFN-γ)和核因子过氧化物酶体增殖物活化受体-γ(PPART)mRNA表达水平;酶联免疫吸附试验(ELISA)法测定血清IL-4和IFN-γ水平及脾脏PPARy、活化T细胞核因子cl(NFATcl)活性。结果(1)15周龄时,吡格列酮组及对照组发病率分别为4.76%和33.33%(P〈0.05);30周龄时,吡格列酮组及对照组发病率分别为57.14%和76.19%(P〉0.05)。(2)12周龄时,吡格列酮组胰岛炎指数(1.79±0.75)低于对照组(2.38±0.66)。(3)吡格列酮组脾脏IFN-γ mRNA相对光密度值(0.16±0.07)显著低于对照组(0.53±0.26);而PPAR7mRNA表达水平(0.91)则高于对照组(0.25)。(4)12周龄NOD鼠吡格列酮组血清IFN-γ水平(561.05±78.61)pg/mL显著低于对照纽(666.434-28.42)pg/mL。(5)12周龄吡格列酮组NOD鼠脾细胞PPAR7活性(0.05±0.01)高于对照组(O.02土0.01),NFATcl活性(0.23±0.04)低于对照组(0.33±0.04)。结论吡格列酮活化PPAR7,降低NFATcl活性,减少IFN-γmRNA,血清IFN-γ下降,辅助性T(Th)细胞向辅助性T细胞1型(Th1)方向分化减少,减轻NoD鼠胰岛炎,降低糖尿病的发生。 Objective To investigate the mechanism of pioglitazone preventing diabetes and the role of nuclear factor of attired T cells (NFAT) on non-obese diabetic(NOD) mice. Methods (1)Female NOD mice at 4 weeks of age were randomly divided into pioglitazone group(n= 21) and control group(n= 21). The accumulative diabetes incidence was followed-up to 30 weeks of age in each group of NOD mice. (2)Pancreas were removed from NOD mice at 12 weeks of age in each group(n= 15) to score insulitis se- verity by routine HE staining. IL-4,IFN-γ, and peroxisome proliferator-activated receptor γ(PPARγ) mRNA levels in spleens were tested by RT PCR. IL-4 and IFN-γ levels in sera,the activity of PPARy and NFATcl nuclear protein in spleens were measured by enzyme linked immunosorbent assay (ELISA). Results (1) At 15 weeks of age,the diabetes incidence was 4.76 % in pioglitazone group,and 33.33G in control group(P〈0.05). At 30 weeks of age,the diabetes incidence was 57.14% in pioglitazone group,and 76.19% in control group(P〉0.05). (2) At 12 weeks of age,the insulitis score in pioglitazone group was lower than that in control groupE(1.79t0.75) vs. (2.38±0.66),P〈0. 051. (3) IFN-γ mRNA level in pioglitazone group was lower than that in control group[(0.16±0.07) vs. (0.53±0.26) ,P〈0.05] ,and PPAR3' mRNA level in pioglitazone group was higher than that in control group(0.91 vs. 0. 25,P〈0.05). (4)IFN-γ, level in pioglitazone group was lower than that in control group [-(561.05±78.61)pg/ mL vs. (666.43±28.42)pg/mL,P〈0. 051. (5)At 12 weeks of age,the spleen PPAR'/nuclear protein activity in pioglitazone group was higher than that in control group (0. 05±0. 01) vs. (0.02±0.01) ,P〈0.05)],and NFATcl nuclear protein activity was low- er than that in control groupr(0.23±0.04) vs. (0.33±0.04) ,P〈0. 051. Conclusion Pioglitazone could activate PPARy nuclear protein,inhibit activity of NFATcl nuclear protein,downr
作者 罗建华 李占伟 黄海 杨冬花 于瑞萍 喻日成 范元硕 刘波 Lu J ianhua ,Li Zhanza,ei2 , Huang Hai2 ,Yang Donghuaa ,Yu Ruiping1 ,Yu Richeng1 ,Fan Yuanshuo1 ,Liu Bo ( 1. Department of Endocrinology, Guizhou Provincial People's Hospital, Guiyang, Guizhou 550002, China 2. Department of Laboratory ,Affiliated Hospital of Guiyang Medical College ,Guiyang ,Guizhou 550004, China; 3. Department of Medicine for Cadre ,Guizhou Provincial People's Hospital ,Guiyang ,Guizhou 550002 ,China)
出处 《重庆医学》 CAS CSCD 北大核心 2013年第31期3792-3794,3797共4页 Chongqing Medical Journal
基金 贵州省优秀科技教育人才省长专项基金资助项目(黔省专合字[2007]60号) 贵州省社会发展攻关项目(黔科合SYE200813051号) 贵阳市科学技术计划项目(E20093筑科农合同字第3-003号) 贵州省高层次人才科研特助基金资助项目(TZJF-2007年-47号).
关键词 糖尿病 胰岛素依赖型 小鼠 近交NOD 过氧化物酶体增殖活化受体γ 活化T细胞核因子 diabetes mellitus, insulin dependent mice, inbred NOD peroxisome proliferator-activated receptor γ nuclear factor of actived T cells
作者简介 罗建华(1974~),副主任医师,博士,主要从事1型糖尿病防治研究。
  • 相关文献

参考文献17

  • 1Driver JP,Serreze DV, Chen YG. Mouse models for thestudy of autoimmune type 1 diabetes: a NOD to similari-ties and differences to human disea.se[J]. Semin Immuno-patKoU20ll,33(l) :67-87. 被引量:1
  • 2裴剑浩 ,周智广 ,罗建华 ,蒋铁建 ,李霞 ,何凌 .吡格列酮对非肥胖性糖尿病小鼠糖尿病的预防作用及机理探讨[J].中华医学杂志,2004,84(5):411-415. 被引量:16
  • 3罗建华 ,周智广 ,蒋铁建 ,裴剑浩 ,李霞 ,何凌 ,孙曙光 .人谷氨酸脱羧酶65DNA疫苗预防非肥胖糖尿病小鼠糖尿病的机制探讨[J].中华医学杂志,2004,84(21):1791-1795. 被引量:8
  • 4Quinn CE, Hamilton PK,Lockhart CJ ,et al. Thiazolidine-diones: effects on insulin resistance and the cardiovascularsystem[J]. Br J Pharmacol,2008,153(4) :636-645. 被引量:1
  • 5Koufany M,Moulin D,Bianchi A,et al. Anti-inflammatoryeffect of antidiabetic thiazolidinediones prevents bone re-sorption rather than cartilage changes in experimentalpolyarthritis[J]. Arthritis Res Ther,2008,10( 1) :60-65. 被引量:1
  • 6孙曙光,周智广,张松,罗建华,孙意,张翼.吡格列酮对NOD鼠糖尿病的预防作用及其机制探讨[J].中国糖尿病杂志,2007,15(4):235-238. 被引量:5
  • 7Guri AJ,Mohapatra SK, Horne WT, et al. The role of T cellPPAR gamma in mice with experimental inflammatory boweldisease[J], BMC Gastroenterol.2010,10(10) :60-70. 被引量:1
  • 8Klotz L, Burgdorf S,Dani I, et al. The nuclear receptorPPAR gamma selectively inhibits Thl7 differentiation ina T cell-intrinsic fashion and suppresses CNS autoimmu-nity[J]. J Exp Med,2009,206(10) :2079-2089. 被引量:1
  • 9Schmidt MV,Briine B, Von Knethen A. The nuclear hor-mone receptor PPAR*/ as a therapeutic target in majordiseases[J]. Sci World,2010,10(30) :2181-2197. 被引量:1
  • 10Fukuen S,Iwaki M. Yasui A,et al. Sulfonylurea agentsexhibit peroxisome proliferator- activated receptor gammaagonistic activity[J]. J Biol Chem, 2005 ,280 C 25) : 23653-23659. 被引量:1

二级参考文献27

  • 1罗建华 ,周智广 ,蒋铁建 ,裴剑浩 ,李霞 ,何凌 ,孙曙光 .人谷氨酸脱羧酶65DNA疫苗预防非肥胖糖尿病小鼠糖尿病的机制探讨[J].中华医学杂志,2004,84(21):1791-1795. 被引量:8
  • 2Eshima K, Mora C, Wong FS, et al. A crucial role of CD4 T cells as a functional source of CD154 in the initiation of insulin-dependent diabetes mellitus in the non-obese diabetic mouse. Int Immunol, 2003,35:351-357. 被引量:1
  • 3Kaufman DL, Clare-Salzler M, Tian J, et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature, 1993, 366: 69-72. 被引量:2
  • 4Yoon JW, Yoon CS, Lim HW, et al. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in β cells. Science ,1999, 284: 1183-1187. 被引量:1
  • 5Yang W, Zhou ZG, Yang ZL, et al. Investigation of glutamic acid decarboxylase and complete Freud′s adjuvant preventing insulitis and diabetes in NOD mice. Natl Med J Chin,1998,78:148-149.杨文,周智广,杨竹林,等. 谷氨酸脱 被引量:3
  • 6Balasa B, Boehm BO, Fortnage A, et al. Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 constimulation circumvents that protection. Clin Immunol,2001,1999: 241-252. 被引量:1
  • 7Tisch R, Wang B, Weaver DJ, et al. Antigen-specific mediated suppression of β cell autoimmunity by plasmid DNA Vaccination. J Immunol, 2001,166: 2122-2132. 被引量:1
  • 8Pei JH, Zhou ZG, Luo JH,et al. Preventive effects of pioglitazone on diabetes and relevant mechanisms, experimental study on non-obese diabetic mouse. Natl Med J Chin, 2004,84:411-415 裴剑浩,周智广,罗建华,等.吡格列酮对非 被引量:1
  • 9Lernmark A, Abdulahi P, Agardh CD, et al. A phase Ⅱ clinical trial involving alum-formulated GAD65 vaccination of GAD65-autoantibody positive adult diabetes patients. 63rd ADA. New Orleans, 2003. 被引量:1
  • 10Constant SL, Bottomly K. Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol, 1997,15:297-322. 被引量:1

共引文献19

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈